BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 19322072)

  • 1. Tranilast inhibits the growth and metastasis of mammary carcinoma.
    Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
    Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
    Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line.
    Ehata S; Hanyu A; Fujime M; Katsuno Y; Fukunaga E; Goto K; Ishikawa Y; Nomura K; Yokoo H; Shimizu T; Ogata E; Miyazono K; Shimizu K; Imamura T
    Cancer Sci; 2007 Jan; 98(1):127-33. PubMed ID: 17129361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
    Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
    Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
    Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
    Mitra SK; Lim ST; Chi A; Schlaepfer DD
    Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
    Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
    J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranilast (N-3,4-dimethoxycinamoyl anthranilic acid): a novel inhibitor of invasion-stimulating interaction between gastric cancer cells and orthotopic fibroblasts.
    Yashiro M; Murahashi K; Matsuoka T; Nakazawa K; Tanaka H; Osaka H; Koyama T; Ohira M; Chung KH
    Anticancer Res; 2003; 23(5A):3899-904. PubMed ID: 14666694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism.
    Yang L; Huang Y; Porta R; Yanagisawa K; Gonzalez A; Segi E; Johnson DH; Narumiya S; Carbone DP
    Cancer Res; 2006 Oct; 66(19):9665-72. PubMed ID: 17018624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma.
    Pulaski BA; Smyth MJ; Ostrand-Rosenberg S
    Cancer Res; 2002 Aug; 62(15):4406-12. PubMed ID: 12154047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.
    Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A
    Breast Cancer Res Treat; 2008 Jan; 107(1):33-40. PubMed ID: 17333337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
    Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical enhancers of cytokine signaling that suppress microfilament turnover and tumor cell growth.
    Park HJ; Partridge E; Cheung P; Pawling J; Donovan R; Wrana JL; Dennis JW
    Cancer Res; 2006 Apr; 66(7):3558-66. PubMed ID: 16585180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination.
    Perry K; Wong L; Liu V; Park I; Zhang Q; Rejen V; Huang X; Smith ND; Jovanovic B; Lonning S; Teicher BA; Lee C
    Urology; 2008 Jul; 72(1):225-9. PubMed ID: 18295867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer.
    Hahn T; Szabo L; Gold M; Ramanathapuram L; Hurley LH; Akporiaye ET
    Cancer Res; 2006 Oct; 66(19):9374-8. PubMed ID: 17018590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice.
    Zugmaier G; Paik S; Wilding G; Knabbe C; Bano M; Lupu R; Deschauer B; Simpson S; Dickson RB; Lippman M
    Cancer Res; 1991 Jul; 51(13):3590-4. PubMed ID: 2054795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
    Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
    Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation of p21 by Tranilast is mediated via transforming growth factor beta signal pathway.
    Charng MJ; Wu CH
    Br J Pharmacol; 2006 Jan; 147(1):117-24. PubMed ID: 16284627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots.
    Kimura Y; Taniguchi M; Baba K
    Planta Med; 2004 Mar; 70(3):211-9. PubMed ID: 15114497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.